Symbols

EXAS(Delisted)

Exact Sciences·NASDAQ

--(--)

EXAS fundamentals

EXAS Q3 2025 Earnings

Exact Sciences (EXAS) released its earnings on Nov 3, 2025: revenue was 850.74M (YoY +20.05%), beat estimates; EPS was -0.1 (YoY +52.38%), missed estimates.

Revenue / YoY

850.74M

+20.05%

EPS / YoY

-0.1

+52.38%

Report date

Nov 3, 2025

EXAS Earnings Call Summary for Q3,2025

Revenue Supercharge: 20% YoY growth to $851M, driven by Cologuard's 22% surge and 0.25M+ new screenings.
Cologuard Plus Dominance: 95% sensitivity, 4 top payers contracted, targeting 30%+ volume.
Cancerguard Launch: Direct-to-consumer ads, 200k+ provider network engagement.
Cash Flow Powerhouse: $236M free cash flow YTD (+270%), 16% EBITDA margins.
Freenome Milestone: V2 data Q4, V1 FDA review for CRC blood test.
2026 Vision: 15%+ CAGR, 20%+ screening growth pace, 70%+ rescreen penetration.

Earnings

EPS

Revenue

Revenue & Expenses

EXAS has released its 2025 Q4 earnings report, with revenue of 878.38M, reflecting a YoY change of 23.12%, and net profit of -85.95M, showing a YoY change of 90.06%. The Sankey diagram below clearly presents EXAS's revenue sources and cost distribution.

Key Indicators

Exact Sciences (EXAS) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Exact Sciences (EXAS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Exact Sciences (EXAS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Exact Sciences (EXAS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Exact Sciences (EXAS) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Exact Sciences (EXAS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data